Clinical outcomes during and after wearable cardioverter defibrillator use in Japanese patients with heart failure: A single‐center experience

Documenti analoghi

• Survival benefit of primary prevention implantable cardioverter‐defibrillator/cardiac resynchronization therapy with a defibrillator: Analysis of the Japan cardiac device treatment registry and Japanese cardiac registry of heart failure in cardiology
  di: Hisashi Yokoshiki, et al.
  Pubblicazione: (2025)
• Multicenter prospective observational study to clarify the current status and clinical outcome in Japanese patients who have an indication for implantable cardioverter defibrillator (ICD) or wearable cardioverter defibrillator (WCD) (TRANSITION JAPAN‐ICD/WCD study): Rationale and design of a prospective, multicenter, observational, comparative study
  di: Yukitoshi Ikeya, et al.
  Pubblicazione: (2024)
• How to indicate implantable cardioverter‐defibrillator in the aging population
  di: Risako Orita, et al.
  Pubblicazione: (2025)
• Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
  di: Yuki Konno, et al.
  Pubblicazione: (2025)
• Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
  di: Hirota Kida, et al.
  Pubblicazione: (2025)